Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Stejbach Mark
Relationship:   Director
City:   East Norriton
State:   PA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   79,728    

Indirect Shares

   1,580      
Direct Value   $1,220,964    

Indirect Value

   $14,410      
Total Shares   81,308      
Total Value   $1,235,374      


Tengion Inc $0 Alkermes Plc $1,220,964 Tengion Inc $0 Alkermes Plc $1,220,964
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    0    

     Stock price went up :
    1   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   1.0   
   0.0   
     Percentage Gain/Loss :
   17.8%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Tengion Inc TNGN VP and Chief Commercia... 2011-05-11 28,663 2010-04-09 0    Premium*  
            Alkermes Plc ALKS SVP/Chief Comm Off, Al... 2018-03-03 51,065 0    Premium*  
            Flexion Therapeutics Inc FLXN Director 2021-11-19 0 2020-06-10 1,580    Premium*  
* Premium Members only  

Records found :    61         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
TNGN Tengion Inc VP & Chief Commercial Officer   •       –      –    2010-04-14 4 A $0.00 $0 D/D 1,896 1,996 0 -
TNGN Tengion Inc VP and Chief Commercial Offcr   •       –      –    2011-05-11 4 A $0.00 $0 D/D 26,667 28,663 0 -
ALKS Alkermes Plc Chief Commercial Officer   •       •      –    2015-10-05 4 A $0.00 $0 D/D 5,000 21,640 0 -
FLXN Flexion Therapeutics Inc Director   –       •      –    2020-06-10 4 A $0.00 $0 D/D 4,500 6,551 0 -
FLXN Flexion Therapeutics Inc Director   –       •      –    2021-06-24 4 A $0.00 $0 D/D 4,500 12,631 0 -
ALKS Alkermes Plc Chief Commercial Officer   •       •      –    2015-11-02 4 AS $72.00 $1,297,168 D/D (18,000) 19,964 0 -
ALKS Alkermes Plc Chief Commercial Officer   •       •      –    2015-12-01 4 AS $71.99 $1,299,209 D/D (18,000) 19,564 0 -
ALKS Alkermes Plc Chief Commercial Officer   •       •      –    2015-12-28 4 AS $80.24 $802,392 D/D (10,000) 19,564 0 -
ALKS Alkermes Plc SVP/Chief Comm Off, Alks Inc   •       •      –    2017-01-04 4 AS $60.01 $150,018 D/D (2,500) 34,115 0 -
ALKS Alkermes Plc SVP/Chief Comm Off, Alks Inc   •       •      –    2017-01-05 4 AS $60.09 $18,026 D/D (300) 34,115 0 -
ALKS Alkermes Plc SVP/Chief Comm Off, Alks Inc   •       •      –    2017-01-06 4 AS $60.07 $399,643 D/D (6,653) 34,115 0 -
ALKS Alkermes Plc SVP/Chief Comm Off, Alks Inc   •       •      –    2017-01-09 4 AS $60.27 $32,968 D/D (547) 34,115 0 -
ALKS Alkermes Plc SVP/Chief Comm Off, Alks Inc   •       •      –    2017-06-08 4 AS $60.34 $603,352 D/D (10,000) 44,013 0 -
ALKS Alkermes Plc SVP/Chief Comm Off, Alks Inc   •       •      –    2018-02-16 4 AS $70.50 $767,092 D/D (10,880) 44,013 0 -
TNGN Tengion Inc VP & Chief Commercial Officer   •       –      –    2010-04-09 4 B $5.00 $500 D/D 100 100 2.66 -
ALKS Alkermes Plc Chief Commercial Officer   •       •      –    2012-11-13 4 B $20.13 $24,156 D/D 1,200 1,400 2.74 -
FLXN Flexion Therapeutics Inc Director   –       •      –    2017-06-16 4 B $17.02 $26,888 I/I 1,580 1,580 2.1 -
FLXN Flexion Therapeutics Inc Director   –       •      –    2020-05-26 4 B $9.75 $19,997 D/D 2,051 2,051 2.39 %
ALKS Alkermes Plc Chief Commercial Officer   •       •      –    2014-05-28 4 D $45.74 $37,232 D/D (814) 8,866 0 -
ALKS Alkermes Plc Chief Commercial Officer   •       •      –    2015-03-03 4 D $72.80 $66,539 D/D (914) 10,764 0 -
ALKS Alkermes Plc Chief Commercial Officer   •       •      –    2015-04-15 4 D $62.83 $99,963 D/D (1,591) 14,953 0 -
ALKS Alkermes Plc Chief Commercial Officer   •       •      –    2015-05-28 4 D $59.92 $48,715 D/D (813) 16,640 0 -
ALKS Alkermes Plc Chief Commercial Officer   •       •      –    2015-10-05 4 D $59.77 $100,175 D/D (1,676) 19,964 0 -
ALKS Alkermes Plc SVP/Chief Comm Off, Alks Inc   •       •      –    2016-02-26 4 D $33.61 $28,636 D/D (852) 21,337 0 -
ALKS Alkermes Plc SVP/Chief Comm Off, Alks Inc   •       •      –    2016-10-05 4 D $46.43 $75,356 D/D (1,623) 30,027 0 -
  61  Records found
  1  2   3      
  Page 1 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us